TNFRSF17 and Miyoshi myopathy: The extracellular domain of membrane-bound BCMA may be cleaved by γ-secretase resulting in the release of soluble BCMA (sBCMA) into the plasma, high levels of which have been correlated with poor clinical outcomes in MM patients.